Literature DB >> 1495303

Results of surgical treatment for roentgenographically occult bronchogenic squamous cell carcinoma.

Y Saito1, N Nagamoto, S Ota, M Sato, M Sagawa, K Kamma, S Takahashi, K Usuda, C Endo, T Imai.   

Abstract

Ninety-four patients with roentgenographically occult bronchogenic squamous cell carcinoma had surgical resection. Fifty-three reported having no symptoms. In 83 carcinoma was detected by cytologic examination of the sputum during lung cancer screening. The carcinomas were located in segmental bronchi (34 cases), subsegmental bronchi (19 cases), divisional bronchi (17 cases), and subsubsegmental or more peripheral bronchi (15 cases). The number of cases classified by TNM staging were 16 Tis N0 M0, 72 T1 N0 M0, 4 T1 N1 M0, and 2 T2 N1 M0. Extrabronchial invasion of the resected carcinoma was observed in 17 lesions (16 cases). Five of six patients with lymph node metastasis in the resected specimens had carcinoma with extrabronchial invasion. Multiple primary lung cancers were observed in nine patients at the time of operation and in seven subsequently. Four of seven patients with subsequent primary lung cancer had surgical resection, and no recurrence was observed after the second operation. There were two deaths from lung cancer: One was caused by subsequent primary lung cancer and the other by mediastinal lymph node metastasis. In the 75 patients with intrabronchial cancer invasion and without lymph node metastasis who had complete resection, there was no local recurrence or metastasis of cancer. The 5-year survivals were 80.4% (death from all causes) and 93.5% (death from lung cancer). Although subsequent primary lung cancer is troublesome, operation is a reliable treatment for occult bronchogenic squamous cell carcinoma.

Entities:  

Mesh:

Year:  1992        PMID: 1495303

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

Review 1.  Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.

Authors:  A K Banerjee; P H Rabbitts; J George
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 2.  Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer.

Authors:  Paola Ulivi; Rosella Silvestrini
Journal:  Cell Oncol (Dordr)       Date:  2013-11-01       Impact factor: 6.730

Review 3.  Early central airways lung cancer.

Authors:  Chiaki Endo; Akira Sakurada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-07-19

4.  Allelic loss on 17p13 (TP53) and allelic loss on 3p21 in early squamous cell carcinoma of the lung.

Authors:  C Endo; M Sato; S Fujimura; A Sakurada; H Aikawa; S Takahashi; K Usuda; Y Saito; M Sagawa
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

5.  Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.

Authors:  John Yee; Marianne D Sadar; Don D Sin; Michael Kuzyk; Li Xing; Jennifer Kondra; Annette McWilliams; S F Paul Man; Stephen Lam
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

6.  Comparison of endoscopic features of early-stage squamous cell lung cancer and histological findings.

Authors:  C Konaka; T Hirano; H Kato; K Furuse; M Takada; Y Saito; Y Monden; E Matsui; Y Watanabe
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

7.  Multiple marker detection in peripheral blood for NSCLC diagnosis.

Authors:  Paola Ulivi; Laura Mercatali; Gian-Luca Casoni; Emanuela Scarpi; Lauro Bucchi; Rosella Silvestrini; Stefano Sanna; Marco Monteverde; Dino Amadori; Venerino Poletti; Wainer Zoli
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

8.  Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung.

Authors:  C Endo; M Sagawa; M Sato; Y Chen; A Sakurada; H Aikawa; S Takahashi; K Usuda; Y Saito; S Fujimura
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

9.  Nodular-type central squamous cell lung carcinoma cured by intraluminal bronchoscopic treatment: A case report.

Authors:  Hikaru Aoki; Keigo Uchimura; Tatsuya Imabayashi; Yuji Matsumoto; Masahiro Higashiyama; Shun-Ichi Watanabe; Takaaki Tsuchida
Journal:  Thorac Cancer       Date:  2021-07-28       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.